Anteris Technologies treats 100+ patients with DurAVR THV for aortic stenosis

Multinational company Anteris Technologies Global Corp, is a head in Structural heart solutions, and it has reached an essential achievement with its DurAVR Transcatheter Heart valve(THV). Over 100 patients suffering from severe aortic stenosis

AiMED supports Govt's initiative to boost medical devices sector with EPCMD

The Association Indian Medical Device Industry (AiMED) congratulates the government's announcement to operationalise the...

GE Healthcare unveils new CT System, aiming to Improve CVD Diagnosis

GE HealthCare introduced its new computed tomography (CT) system, intended to support healthcare professionals in diagnosing difficult coronary artery disease (CAD)...

Musk: Neuralink's Blindsight vision chip to be implanted in humans by 2025

Billionaire Elon Musk announced that his brain chip firm Neuralink intends to conduct its first Blindsight implant by the end of 2025. The artificial visual prosthesis aims to give blind people their sight back...

Glenmark Pharma launches broad-spectrum antibiotic for bacterial pathogens

Glenmark Pharmaceuticals Inc., USA, has announced the commercial availability of Vancomycin Hydrochloride for Injection USP in three single-dose vial strengths: 750 mg/vial, 1.25 g/vial, and 1.5...

Gennova Biopharma speeds up Nipah virus vaccine development with mRNA tech

Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals based in Pune, is advancing the creation of an innovative self-amplifying mRNA (saRNA) vaccine against the Nipah virus.This important effort has been made possible by an expansion of

Government Enhances Research & Integration Initiatives in Unani Medicine

The Indian government is providing more support to the Unani system as it links it with modern healthcare and advances its research. Key infrastructural developments under the...

India Urged to Negotiate from Strength on US Tariffs in Pharma Dispute

The government of India is being urged by its pharmaceutical industry to negotiate with Washington from a position of power on tariffs set to take effect next week, rather than yield to the pressure...

CDSCO Flags 103 Drugs as Substandard, Warns of Spurious Telma H Batch

103 drugs and formulations have been labelled as Not of Standard Quality (NSQ) by the countrys apex drug regulator, while a batch of popular hypertension medicine Telma H has been flagged as spurious.

Blind & Deaf individuals face Major Barriers to access Medicines: Report

A new report has thrown light on the difficulty suffered by deaf and blind people in procuring medicines and medical devices. Experts warned against major deficiencies in...

© 2025 India Pharma Outlook. All Rights Reserved.